Home › Companies › Wave Life Sciences Ltd. › 2025-2026

Wave Life Sciences Ltd. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Wave Life Sciences Ltd.’s Form 8-K, filed 2025-08-11 (Item 5.07 on EDGAR). Page generated 02 October 2026.

22Reported items
198Asset managers
3,396Fund votes
2025-08-05Main meeting date

Proxy season: 2024-2025 2025-2026

Explore Wave Life Sciences Ltd. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Wave Life Sciences Ltd.

These tallies are Wave Life Sciences Ltd.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-08-11 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Wave Life Sciences Ltd. — official shareholder meeting results, meeting held 2025-08-05
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Paul B. Bolno, M.D., MBA	129,131,201	1,501,235	8,680	--	14,529,462	Majority: yes
Elect Director: Mark H.N. Corrigan, M.D.	129,548,443	1,084,930	7,743	--	14,529,462	Majority: yes
Elect Director: Christian Henry	111,549,230	19,074,532	17,354	--	14,529,462	Majority: yes
Elect Director: Peter Kolchinsky, Ph.D.	130,188,145	444,723	8,248	--	14,529,462	Majority: yes
Elect Director: Adrian Rawcliffe	130,337,320	285,647	18,149	--	14,529,462	Majority: yes
Elect Director: Ken Takanashi	124,467,167	6,024,248	149,701	--	14,529,462	Majority: yes
Elect Director: Aik Na Tan	130,362,062	269,697	9,357	--	14,529,462	Majority: yes
Elect Director: Gregory L. Verdine, Ph.D.	130,098,845	521,198	21,073	--	14,529,462	Majority: yes
Elect Director: Heidi L. Wagner, J.D.	125,980,141	4,281,064	379,911	--	14,529,462	Majority: yes

Source: Wave Life Sciences Ltd., Form 8-K, filed with the SEC on 2025-08-11 — read the filing on EDGAR.

How asset managers voted at the Wave Life Sciences Ltd. 2025-2026 meetings

Each item below shows how the 198 asset managers that disclosed a Wave Life Sciences Ltd. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Wave Life Sciences Ltd.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-08-05.

Combines 4 wordings of this item as funds reported it.

99.7% fund support · no official result

FOR 99.7%

The 189 asset managers below cast 99.7% of the shares they voted on this item FOR (123,082,376 for, 309,005 against).

FOR: 123,082,376 (99.7%)AGAINST: 309,005 (0.3%)ABSTAIN: 18,157 (0.0%)NOT VOTED: 940 (0.0%)

Largest asset managers voting on “To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in t” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Against	Vote
ADAGE CAPITAL PARTNERS GP, L.L.C.	14,462,384	0	For
RA CAPITAL MANAGEMENT, L.P.	12,988,358	0	For
BlackRock	9,787,247	9,277	For
T. Rowe Price	8,447,063	0	For
MAVERICK CAPITAL LTD	6,541,967	0	For
M28 Capital Management LP	5,664,548	0	For
Loomis Sayles	5,062,249	0	For
PRIMECAP MANAGEMENT CO/CA/	4,957,000	0	For
DRIEHAUS CAPITAL MANAGEMENT LLC	4,352,886	0	For
Charles Schwab	4,010,270	0	For
Vanguard	3,453,082	0	For
683 Capital Management, LLC	3,425,335	0	For
Fidelity	3,358,630	0	For
Siren, L.L.C.	3,155,227	0	For
GEODE CAPITAL MANAGEMENT, LLC	2,615,926	0	For
PRIMECAP Odyssey Funds	2,378,380	0	For
State Street	2,185,488	294	For
Artisan	2,055,536	0	For
Polar Capital Holdings Plc	2,007,000	0	For
EMERALD MUTUAL FUND ADVISERS TRUST	1,937,066	0	For
EMERALD ADVISERS, LLC	1,773,503	0	For
MPM BioImpact LLC	1,505,262	0	For
Principal	1,400,995	0	For
RBB FUND, INC.	1,329,191	0	For
Kynam Capital Management, LP	1,305,356	0	For

Showing the 25 largest of 189 asset managers. See all 189 in the interactive database.

2. TO APPROVE, ON A NON-BINDING, ADVISORY BASIS ONLY, THE FREQUENCY OF HOLDING FUTURE SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-08-05.

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

ONE YEAR 58%1 YEAR 40%

The 189 asset managers below cast 100% of the shares they voted on this item FOR (2,700,194 for, 0 against).

FOR: 2,700,194 (2.2%)ABSTAIN: 6,157 (0.0%)ONE YEAR: 71,066,704 (57.6%)1 YEAR: 48,824,267 (39.6%)1-YEAR: 452,060 (0.4%)3 YEARS: 314,256 (0.3%)1.0: 15,000 (0.0%)1: 12,000 (0.0%)NOT VOTED: 940 (0.0%)

Largest asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS ONLY, THE FREQUENCY OF HOLDING FUTURE SHAREHOLDER ADVISORY VOTES ” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Vote
ADAGE CAPITAL PARTNERS GP, L.L.C.	0	One Year
RA CAPITAL MANAGEMENT, L.P.	0	One Year
BlackRock	868,754	1 Year
T. Rowe Price	0	One Year
MAVERICK CAPITAL LTD	0	1 Year
M28 Capital Management LP	0	1 Year
Loomis Sayles	0	One Year
PRIMECAP MANAGEMENT CO/CA/	0	1 Year
DRIEHAUS CAPITAL MANAGEMENT LLC	0	One Year
Charles Schwab	0	1 Year
Vanguard	0	One Year
683 Capital Management, LLC	0	One Year
Fidelity	0	One Year
Siren, L.L.C.	0	1 Year
GEODE CAPITAL MANAGEMENT, LLC	0	One Year
PRIMECAP Odyssey Funds	0	1 Year
State Street	0	One Year
Artisan	0	One Year
Polar Capital Holdings Plc	0	One Year
EMERALD MUTUAL FUND ADVISERS TRUST	0	1 Year
EMERALD ADVISERS, LLC	0	1 Year
MPM BioImpact LLC	0	1 Year
Principal	0	One Year
RBB FUND, INC.	0	1 Year
Kynam Capital Management, LP	1,305,356	For

Showing the 25 largest of 189 asset managers. See all 189 in the interactive database.

3. To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by shares incorporated under the laws of the Republic of Singapore ("Wave- Singapore"), the shareholders of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation, subject to approval of the High Court of the Republic of Singapore, as set forth in Wave- Singapore's notice o

EXTRAORDINARY TRANSACTIONS

Meeting held 2026-06-22; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 57 asset managers below cast 100% of the shares they voted on this item FOR (37,821,859 for, 0 against).

FOR: 37,821,859 (100.0%)ABSTAIN: 16,522 (0.0%)

Largest asset managers voting on “To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limit” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	6,970,078	0	For
T. Rowe Price	6,239,907	0	For
Fidelity	6,072,674	0	For
Federated Hermes	3,956,251	0	For
PRIMECAP Odyssey Funds	3,839,708	0	For
Vanguard	2,800,796	0	For
Charles Schwab	1,179,438	0	For
DRIEHAUS MUTUAL FUNDS	954,004	0	For
State Street	648,661	0	For
RBB FUND, INC.	575,215	0	For
TIAA	506,940	0	For
Bridge Builder Trust	437,881	0	For
Equitable	334,279	0	For
Dimensional	321,412	0	For
Principal	313,073	0	For
Brighthouse	217,375	16,522	For
QUANTITATIVE MASTER SERIES LLC	227,083	0	For
TRUST FOR PROFESSIONAL MANAGERS	201,259	0	For
Prudential/PGIM	191,784	0	For
JPMorgan	178,682	0	For
Jackson National	163,767	0	For
Global X	120,936	0	For
Invesco	116,270	0	For
Nuveen	110,929	0	For
Transamerica	110,824	0	For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

4. To approve our payment of cash and equity-based compensation to non-employee directors for service on the Board of Directors and its committees, in the manner and on the basis set forth under "Proposal 3: Non-Employee Directors' Compensation" in the proxy statement.

OTHER

Meeting held 2025-08-05.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 57 asset managers below cast 100% of the shares they voted on this item FOR (27,681,476 for, 0 against).

FOR: 27,681,476 (100.0%)

Largest asset managers voting on “To approve our payment of cash and equity-based compensation to non-employee directors for service on the Boar” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Vote
BlackRock	5,059,945	For
T. Rowe Price	3,529,395	For
Vanguard	3,171,588	For
Fidelity	2,841,700	For
PRIMECAP Odyssey Funds	2,378,380	For
Charles Schwab	1,977,032	For
Loomis Sayles	1,812,031	For
Principal	1,400,995	For
RBB FUND, INC.	1,329,191	For
DRIEHAUS MUTUAL FUNDS	916,023	For
Brighthouse	458,504	For
State Street	296,459	For
Equitable	250,595	For
Global X	246,659	For
TIAA	218,371	For
Prudential/PGIM	197,329	For
OPTIMUM FUND TRUST	186,213	For
QUANTITATIVE MASTER SERIES LLC	181,521	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	For
Jackson National	124,776	For
AIG/SunAmerica	106,704	For
Delaware/Macquarie	81,955	For
Lincoln Financial	73,500	For
John Hancock	67,549	For
GuideStone	66,693	For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

5. The election of the nominees for director: Adrian Rawcliffe

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-05.

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%

FOR: 130,337,320AGAINST: 285,647

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Adrian Rawcliffe”): 130,337,320 for, 285,647 against, per its Form 8-K filed 2025-08-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 155,673,292 outstanding shares: 84% for, 0.2% against (84% of the company cast a for/against vote).

The 55 asset managers below cast 99.9% of the shares they voted on this item FOR (28,274,133 for, 437 against).

FOR 99.9%

FOR: 28,274,133 (100.0%)AGAINST: 437 (0.0%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “The election of the nominees for director: Adrian Rawcliffe” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	5,059,945	0	For
T. Rowe Price	3,529,395	0	For
Vanguard	3,171,588	0	For
Fidelity	2,841,700	0	For
PRIMECAP Odyssey Funds	2,378,380	0	For
Charles Schwab	1,977,032	0	For
Loomis Sayles	1,812,031	0	For
Principal	1,400,995	0	For
RBB FUND, INC.	1,329,191	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	For
Brighthouse	513,166	6,157	For
JPMorgan	324,142	0	For
State Street	296,459	0	For
HUSSMAN INVESTMENT TRUST	252,000	0	For
Equitable	250,595	0	For
Global X	246,659	0	For
TIAA	218,371	0	For
Prudential/PGIM	197,329	0	For
OPTIMUM FUND TRUST	186,213	0	For
QUANTITATIVE MASTER SERIES LLC	181,521	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	For
Jackson National	124,776	0	For
AIG/SunAmerica	106,704	0	For
Lincoln Financial	85,268	0	For
Delaware/Macquarie	81,955	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

6. The election of the nominees for director: Aik Na Tan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-05.

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%

FOR: 130,362,062AGAINST: 269,697

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Aik Na Tan”): 130,362,062 for, 269,697 against, per its Form 8-K filed 2025-08-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 155,673,292 outstanding shares: 84% for, 0.2% against (84% of the company cast a for/against vote).

The 55 asset managers below cast 100% of the shares they voted on this item FOR (28,274,570 for, 0 against).

FOR 99.9%

FOR: 28,274,570 (100.0%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “The election of the nominees for director: Aik Na Tan” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	5,059,945	0	For
T. Rowe Price	3,529,395	0	For
Vanguard	3,171,588	0	For
Fidelity	2,841,700	0	For
PRIMECAP Odyssey Funds	2,378,380	0	For
Charles Schwab	1,977,032	0	For
Loomis Sayles	1,812,031	0	For
Principal	1,400,995	0	For
RBB FUND, INC.	1,329,191	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	For
Brighthouse	513,166	6,157	For
JPMorgan	324,142	0	For
State Street	296,459	0	For
HUSSMAN INVESTMENT TRUST	252,000	0	For
Equitable	250,595	0	For
Global X	246,659	0	For
TIAA	218,371	0	For
Prudential/PGIM	197,329	0	For
OPTIMUM FUND TRUST	186,213	0	For
QUANTITATIVE MASTER SERIES LLC	181,521	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	For
Jackson National	124,776	0	For
AIG/SunAmerica	106,704	0	For
Lincoln Financial	85,268	0	For
Delaware/Macquarie	81,955	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

7. The election of the nominees for director: Christian Henry

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-05.

Combines 3 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST 15%

FOR: 111,549,230AGAINST: 19,074,532

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Christian Henry”): 111,549,230 for, 19,074,532 against, per its Form 8-K filed 2025-08-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 155,673,292 outstanding shares: 72% for, 12% against (84% of the company cast a for/against vote).

The 55 asset managers below cast 52.9% of the shares they voted on this item FOR (14,948,481 for, 13,326,089 against).

FOR 52.9%AGAINST 47.1%

FOR: 14,948,481 (52.9%)AGAINST: 13,326,089 (47.1%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “The election of the nominees for director: Christian Henry” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Against	Abstain	Vote
BlackRock	0	5,059,945	0	Against
T. Rowe Price	3,529,395	0	0	For
Vanguard	0	3,171,588	0	Against
Fidelity	2,794,949	46,751	0	For
PRIMECAP Odyssey Funds	2,378,380	0	0	For
Charles Schwab	0	1,977,032	0	Against
Loomis Sayles	0	1,812,031	0	Against
Principal	1,400,995	0	0	For
RBB FUND, INC.	1,329,191	0	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	0	For
Brighthouse	151,722	361,444	6,157	Against
JPMorgan	324,142	0	0	For
State Street	296,459	0	0	For
HUSSMAN INVESTMENT TRUST	252,000	0	0	For
Equitable	20,377	230,218	0	Against
Global X	0	246,659	0	Against
TIAA	218,371	0	0	For
Prudential/PGIM	197,329	0	0	For
OPTIMUM FUND TRUST	186,213	0	0	For
QUANTITATIVE MASTER SERIES LLC	0	181,521	0	Against
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	0	For
Jackson National	124,776	0	0	For
AIG/SunAmerica	106,704	0	0	For
Lincoln Financial	85,268	0	0	For
Delaware/Macquarie	81,955	0	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

8. The election of the nominees for director: Gregory L. Verdine, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-05.

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 130,098,845AGAINST: 521,198

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Gregory L. Verdine, Ph.D.”): 130,098,845 for, 521,198 against, per its Form 8-K filed 2025-08-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 155,673,292 outstanding shares: 84% for, 0.4% against (84% of the company cast a for/against vote).

The 55 asset managers below cast 99.8% of the shares they voted on this item FOR (28,245,074 for, 29,496 against).

FOR 99.8%

FOR: 28,245,074 (99.9%)AGAINST: 29,496 (0.1%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “The election of the nominees for director: Gregory L. Verdine, Ph.D.” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	5,059,945	0	For
T. Rowe Price	3,529,395	0	For
Vanguard	3,171,588	0	For
Fidelity	2,841,700	0	For
PRIMECAP Odyssey Funds	2,378,380	0	For
Charles Schwab	1,977,032	0	For
Loomis Sayles	1,812,031	0	For
Principal	1,400,995	0	For
RBB FUND, INC.	1,329,191	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	For
Brighthouse	513,166	6,157	For
JPMorgan	324,142	0	For
State Street	296,459	0	For
HUSSMAN INVESTMENT TRUST	252,000	0	For
Equitable	250,595	0	For
Global X	246,659	0	For
TIAA	218,371	0	For
Prudential/PGIM	197,329	0	For
OPTIMUM FUND TRUST	186,213	0	For
QUANTITATIVE MASTER SERIES LLC	181,521	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	For
Jackson National	124,776	0	For
AIG/SunAmerica	106,704	0	For
Lincoln Financial	85,268	0	For
Delaware/Macquarie	81,955	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

9. The election of the nominees for director: Heidi L. Wagner, J.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-05.

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 125,980,141AGAINST: 4,281,064

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Heidi L. Wagner, J.D.”): 125,980,141 for, 4,281,064 against, per its Form 8-K filed 2025-08-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 155,673,292 outstanding shares: 81% for, 3% against (84% of the company cast a for/against vote).

The 55 asset managers below cast 97% of the shares they voted on this item FOR (27,284,889 for, 749,681 against).

FOR 97%

FOR: 27,284,889 (97.3%)AGAINST: 749,681 (2.7%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “The election of the nominees for director: Heidi L. Wagner, J.D.” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Against	Abstain	Vote
BlackRock	5,059,945	0	0	For
T. Rowe Price	3,529,395	0	0	For
Vanguard	3,171,588	0	0	For
Fidelity	2,841,700	0	0	For
PRIMECAP Odyssey Funds	2,378,380	0	0	For
Charles Schwab	1,977,032	0	0	For
Loomis Sayles	1,812,031	0	0	For
Principal	1,400,995	0	0	For
RBB FUND, INC.	1,329,191	0	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	0	For
Brighthouse	513,166	0	6,157	For
JPMorgan	324,142	0	0	For
State Street	0	296,459	0	Against
Equitable	250,595	0	0	For
Global X	0	246,659	0	Against
TIAA	218,371	0	0	For
Prudential/PGIM	197,329	0	0	For
OPTIMUM FUND TRUST	186,213	0	0	For
QUANTITATIVE MASTER SERIES LLC	181,521	0	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	0	For
Jackson National	124,776	0	0	For
AIG/SunAmerica	106,704	0	0	For
Lincoln Financial	11,768	73,500	0	Against
Delaware/Macquarie	0	81,955	0	Against
John Hancock	67,549	0	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

10. The election of the nominees for director: Ken Takanashi

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-05.

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 124,467,167AGAINST: 6,024,248

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Ken Takanashi”): 124,467,167 for, 6,024,248 against, per its Form 8-K filed 2025-08-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 155,673,292 outstanding shares: 80% for, 4% against (84% of the company cast a for/against vote).

The 55 asset managers below cast 84% of the shares they voted on this item FOR (23,838,161 for, 4,436,409 against).

FOR 84%AGAINST 16%

FOR: 23,838,161 (84.3%)AGAINST: 4,436,409 (15.7%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “The election of the nominees for director: Ken Takanashi” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Against	Abstain	Vote
BlackRock	5,059,945	0	0	For
T. Rowe Price	3,529,395	0	0	For
Vanguard	3,171,588	0	0	For
Fidelity	2,841,700	0	0	For
PRIMECAP Odyssey Funds	2,378,380	0	0	For
Charles Schwab	0	1,977,032	0	Against
Loomis Sayles	0	1,812,031	0	Against
Principal	1,400,995	0	0	For
RBB FUND, INC.	1,329,191	0	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	0	For
Brighthouse	151,722	361,444	6,157	Against
JPMorgan	324,142	0	0	For
State Street	296,459	0	0	For
HUSSMAN INVESTMENT TRUST	252,000	0	0	For
Equitable	250,595	0	0	For
Global X	0	246,659	0	Against
TIAA	218,371	0	0	For
Prudential/PGIM	197,329	0	0	For
OPTIMUM FUND TRUST	186,213	0	0	For
QUANTITATIVE MASTER SERIES LLC	181,521	0	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	0	For
Jackson National	124,776	0	0	For
AIG/SunAmerica	106,704	0	0	For
Lincoln Financial	85,268	0	0	For
Delaware/Macquarie	81,955	0	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

11. The election of the nominees for director: Mark H. N. Corrigan, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-05.

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 129,548,443AGAINST: 1,084,930

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Mark H.N. Corrigan, M.D.”): 129,548,443 for, 1,084,930 against, per its Form 8-K filed 2025-08-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 155,673,292 outstanding shares: 83% for, 0.7% against (84% of the company cast a for/against vote).

The 55 asset managers below cast 99.9% of the shares they voted on this item FOR (28,274,133 for, 437 against).

FOR 99.9%

FOR: 28,274,133 (100.0%)AGAINST: 437 (0.0%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “The election of the nominees for director: Mark H. N. Corrigan, M.D.” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	5,059,945	0	For
T. Rowe Price	3,529,395	0	For
Vanguard	3,171,588	0	For
Fidelity	2,841,700	0	For
PRIMECAP Odyssey Funds	2,378,380	0	For
Charles Schwab	1,977,032	0	For
Loomis Sayles	1,812,031	0	For
Principal	1,400,995	0	For
RBB FUND, INC.	1,329,191	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	For
Brighthouse	513,166	6,157	For
JPMorgan	324,142	0	For
State Street	296,459	0	For
HUSSMAN INVESTMENT TRUST	252,000	0	For
Equitable	250,595	0	For
Global X	246,659	0	For
TIAA	218,371	0	For
Prudential/PGIM	197,329	0	For
OPTIMUM FUND TRUST	186,213	0	For
QUANTITATIVE MASTER SERIES LLC	181,521	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	For
Jackson National	124,776	0	For
AIG/SunAmerica	106,704	0	For
Lincoln Financial	85,268	0	For
Delaware/Macquarie	81,955	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

12. The election of the nominees for director: Paul B. Bolno, M.D., MBA

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-05.

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 129,131,201AGAINST: 1,501,235

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Paul B. Bolno, M.D., MBA”): 129,131,201 for, 1,501,235 against, per its Form 8-K filed 2025-08-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 155,673,292 outstanding shares: 83% for, 1.0% against (84% of the company cast a for/against vote).

The 55 asset managers below cast 100% of the shares they voted on this item FOR (28,274,570 for, 0 against).

FOR 99.9%

FOR: 28,274,570 (100.0%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “The election of the nominees for director: Paul B. Bolno, M.D., MBA” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	5,059,945	0	For
T. Rowe Price	3,529,395	0	For
Vanguard	3,171,588	0	For
Fidelity	2,841,700	0	For
PRIMECAP Odyssey Funds	2,378,380	0	For
Charles Schwab	1,977,032	0	For
Loomis Sayles	1,812,031	0	For
Principal	1,400,995	0	For
RBB FUND, INC.	1,329,191	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	For
Brighthouse	513,166	6,157	For
JPMorgan	324,142	0	For
State Street	296,459	0	For
HUSSMAN INVESTMENT TRUST	252,000	0	For
Equitable	250,595	0	For
Global X	246,659	0	For
TIAA	218,371	0	For
Prudential/PGIM	197,329	0	For
OPTIMUM FUND TRUST	186,213	0	For
QUANTITATIVE MASTER SERIES LLC	181,521	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	For
Jackson National	124,776	0	For
AIG/SunAmerica	106,704	0	For
Lincoln Financial	85,268	0	For
Delaware/Macquarie	81,955	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

13. The election of the nominees for director: Peter Kolchinsky, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-05.

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 130,188,145AGAINST: 444,723

Wave Life Sciences Ltd.’s own tally for this item (“Elect Director: Peter Kolchinsky, Ph.D.”): 130,188,145 for, 444,723 against, per its Form 8-K filed 2025-08-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 155,673,292 outstanding shares: 84% for, 0.3% against (84% of the company cast a for/against vote).

The 55 asset managers below cast 100% of the shares they voted on this item FOR (28,274,570 for, 0 against).

FOR 99.9%

FOR: 28,274,570 (100.0%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “The election of the nominees for director: Peter Kolchinsky, Ph.D.” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	5,059,945	0	For
T. Rowe Price	3,529,395	0	For
Vanguard	3,171,588	0	For
Fidelity	2,841,700	0	For
PRIMECAP Odyssey Funds	2,378,380	0	For
Charles Schwab	1,977,032	0	For
Loomis Sayles	1,812,031	0	For
Principal	1,400,995	0	For
RBB FUND, INC.	1,329,191	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	For
Brighthouse	513,166	6,157	For
JPMorgan	324,142	0	For
State Street	296,459	0	For
HUSSMAN INVESTMENT TRUST	252,000	0	For
Equitable	250,595	0	For
Global X	246,659	0	For
TIAA	218,371	0	For
Prudential/PGIM	197,329	0	For
OPTIMUM FUND TRUST	186,213	0	For
QUANTITATIVE MASTER SERIES LLC	181,521	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	For
Jackson National	124,776	0	For
AIG/SunAmerica	106,704	0	For
Lincoln Financial	85,268	0	For
Delaware/Macquarie	81,955	0	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

14. To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement.

OTHER

Meeting held 2025-08-05.

Combines 2 wordings of this item as funds reported it.

97% fund support · no official result

FOR 97%

The 54 asset managers below cast 97% of the shares they voted on this item FOR (26,927,444 for, 727,825 against).

FOR: 26,927,444 (97.3%)AGAINST: 727,825 (2.6%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis ” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Against	Abstain	Vote
BlackRock	5,059,945	0	0	For
T. Rowe Price	3,529,395	0	0	For
Vanguard	3,171,588	0	0	For
Fidelity	2,841,700	0	0	For
PRIMECAP Odyssey Funds	2,378,380	0	0	For
Charles Schwab	1,977,032	0	0	For
Loomis Sayles	1,812,031	0	0	For
Principal	1,393,154	7,841	0	For
RBB FUND, INC.	1,329,191	0	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	0	For
Brighthouse	415,144	37,203	6,157	For
State Street	296,459	0	0	For
Equitable	250,595	0	0	For
Global X	246,659	0	0	For
TIAA	218,371	0	0	For
Prudential/PGIM	197,329	0	0	For
OPTIMUM FUND TRUST	0	186,213	0	Against
QUANTITATIVE MASTER SERIES LLC	181,521	0	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	0	For
Jackson National	124,776	0	0	For
AIG/SunAmerica	0	106,704	0	Against
Delaware/Macquarie	0	81,955	0	Against
Lincoln Financial	73,500	0	0	For
John Hancock	28,868	38,681	0	Against
GuideStone	0	66,693	0	Against

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

15. To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuneration for services provided through the date of our 2026 Annual General Meeting of Shareholders.

OTHER

Meeting held 2025-08-05.

100% fund support · no official result

FOR 99.9%

The 54 asset managers below cast 100% of the shares they voted on this item FOR (27,637,841 for, 0 against).

FOR: 27,637,841 (100.0%)ABSTAIN: 6,157 (0.0%)

Largest asset managers voting on “To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and in” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Abstain	Vote
BlackRock	5,059,945	0	For
T. Rowe Price	3,529,395	0	For
Vanguard	3,171,588	0	For
Fidelity	2,841,700	0	For
PRIMECAP Odyssey Funds	2,378,380	0	For
Charles Schwab	1,977,032	0	For
Loomis Sayles	1,812,031	0	For
Principal	1,400,995	0	For
RBB FUND, INC.	1,329,191	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	For
Brighthouse	452,347	6,157	For
State Street	296,459	0	For
Equitable	250,595	0	For
Global X	246,659	0	For
TIAA	218,371	0	For
Prudential/PGIM	197,329	0	For
OPTIMUM FUND TRUST	186,213	0	For
QUANTITATIVE MASTER SERIES LLC	181,521	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	For
Jackson National	124,776	0	For
AIG/SunAmerica	106,704	0	For
Delaware/Macquarie	81,955	0	For
Lincoln Financial	73,500	0	For
John Hancock	67,549	0	For
GuideStone	66,693	0	For

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

16. To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.

OTHER

Meeting held 2025-08-05.

93% fund support · no official result

FOR 93%

The 54 asset managers below cast 93% of the shares they voted on this item FOR (25,699,836 for, 1,927,343 against).

FOR: 25,699,836 (93.0%)AGAINST: 1,927,343 (7.0%)ABSTAIN: 16,819 (0.1%)

Largest asset managers voting on “To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Against	Abstain	Vote
BlackRock	4,555,850	504,095	0	For
T. Rowe Price	3,529,395	0	0	For
Vanguard	3,171,588	0	0	For
Fidelity	2,841,700	0	0	For
PRIMECAP Odyssey Funds	2,378,380	0	0	For
Charles Schwab	1,977,032	0	0	For
Loomis Sayles	1,812,031	0	0	For
Principal	1,393,154	7,841	0	For
RBB FUND, INC.	1,329,191	0	0	For
DRIEHAUS MUTUAL FUNDS	916,023	0	0	For
Brighthouse	415,144	38,541	4,819	For
State Street	0	296,459	0	Against
Equitable	191,215	59,380	0	For
Global X	246,659	0	0	For
TIAA	0	218,371	0	Against
Prudential/PGIM	197,329	0	0	For
OPTIMUM FUND TRUST	0	186,213	0	Against
QUANTITATIVE MASTER SERIES LLC	181,521	0	0	For
TRUST FOR PROFESSIONAL MANAGERS	172,731	0	0	For
Jackson National	124,776	0	0	For
AIG/SunAmerica	0	106,704	0	Against
Delaware/Macquarie	0	81,955	0	Against
Lincoln Financial	0	73,500	0	Against
John Hancock	28,868	38,681	0	Against
GuideStone	0	66,693	0	Against

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

17. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-08-05.

100% fund support · no official result

ONE YEAR 99%

The 4 asset managers below cast 100% of the shares they voted on this item FOR (60,819 for, 0 against).

FOR: 60,819 (1.1%)ONE YEAR: 5,549,561 (98.9%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Vote
RA CAPITAL MANAGEMENT, L.P.	0	One Year
JPMorgan	0	One Year
Brighthouse	60,819	For
Lincoln Financial	0	One Year

18. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-08-05.

100% fund support · no official result

FOR 100%

The 4 asset managers below cast 100% of the shares they voted on this item FOR (5,610,380 for, 0 against).

FOR: 5,610,380 (100.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Vote
RA CAPITAL MANAGEMENT, L.P.	5,213,651	For
JPMorgan	324,142	For
Brighthouse	60,819	For
Lincoln Financial	11,768	For

19. Amend Omnibus Stock Plan

COMPENSATION

Meeting held 2025-08-05.

0% fund support · no official result

AGAINST 100%

The 3 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 396,729 against).

AGAINST: 396,729 (100.0%)

Largest asset managers voting on “Amend Omnibus Stock Plan” at Wave Life Sciences Ltd., 2025-2026
Asset manager	Against	Vote
JPMorgan	324,142	Against
Brighthouse	60,819	Against
Lincoln Financial	11,768	Against

20. Approve Issuance of Shares without Preemptive Rights

CAPITAL STRUCTURE

Meeting held 2025-08-05.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (396,729 for, 0 against).

FOR: 396,729 (100.0%)

Largest asset managers voting on “Approve Issuance of Shares without Preemptive Rights” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Vote
JPMorgan	324,142	For
Brighthouse	60,819	For
Lincoln Financial	11,768	For

21. Approve KPMG LLP as Auditors and Authorize Board to Fix Their Remuneration

AUDIT-RELATED

Meeting held 2025-08-05.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (396,729 for, 0 against).

FOR: 396,729 (100.0%)

Largest asset managers voting on “Approve KPMG LLP as Auditors and Authorize Board to Fix Their Remuneration” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Vote
JPMorgan	324,142	For
Brighthouse	60,819	For
Lincoln Financial	11,768	For

22. Approve Non-Employee Directors' Compensation

COMPENSATION

Meeting held 2025-08-05.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (396,729 for, 0 against).

FOR: 396,729 (100.0%)

Largest asset managers voting on “Approve Non-Employee Directors' Compensation” at Wave Life Sciences Ltd., 2025-2026
Asset manager	For	Vote
JPMorgan	324,142	For
Brighthouse	60,819	For
Lincoln Financial	11,768	For

Largest Wave Life Sciences Ltd. shareholders voting in 2025-2026

Ranked by the number of Wave Life Sciences Ltd. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 155,673,292 shares outstanding at the time of that meeting.

Top Wave Life Sciences Ltd. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	ADAGE CAPITAL PARTNERS GP, L.L.C.	9.29%
2	RA CAPITAL MANAGEMENT, L.P.	8.34%
3	BlackRock	6.29%
4	T. Rowe Price	5.43%
5	MAVERICK CAPITAL LTD	4.20%
6	M28 Capital Management LP	3.64%
7	Loomis Sayles	3.25%
8	PRIMECAP MANAGEMENT CO/CA/	3.18%
9	DRIEHAUS CAPITAL MANAGEMENT LLC	2.80%
10	Charles Schwab	2.58%

Reported Wave Life Sciences Ltd. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Wave Life Sciences Ltd. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
RA Capital Management, L.P.	22.04%	13D
BlackRock	9.07%	13F
T. Rowe Price	5.59%	13F
FMR (Fidelity)	3.34%	13F
State Street	2.36%	13F
Geode Capital	2.30%	13F
Vanguard Group	2.30%	13F
Citadel Advisors	1.81%	13F
Two Sigma	1.21%	13F
Goldman Sachs	0.89%	13F

Percentages above are of 155,673,292 shares outstanding, as reported by Wave Life Sciences Ltd. on its Form 10-Q dated 2025-06-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Wave Life Sciences Ltd.’s 10-Q dated 2025-06-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Wave Life Sciences Ltd.'s 2 shareholder meetings in the 2025-2026 proxy season (held 2025-08-05 and 2026-06-22), 198 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,396 separate fund positions. Their filings are grouped here into 22 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Wave Life Sciences Ltd.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, by a non-binding advisory vote, the compensation of our named executive officers as… — the reporting funds cast 99.7% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Wave Life Sciences Ltd. proxy season coverage: 2024-2025 · 2025-2026 (this page).